Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
350 GBX | -0.57% | +12.90% | +23.67% |
05:11am | Hutchmed Starts Phase 2/3 Trials for Pancreatic Cancer Drug in China; Shares Rise 3% | MT |
05:01am | Hutchmed Begins Phase 3 Trials for Leukemia Medication in China | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.67% | 3.75B | |
+29.98% | 682B | |
+30.34% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.21% | 240B | |
+9.66% | 209B | |
-6.83% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- HCM Stock
- News HUTCHMED (China) Limited
- Transcript : HUTCHMED Limited Presents at Bank of America Securities 2023 Healthcare Conference, May-10-2023 03